GENE ONLINE|News &
Opinion
Blog

Special
Ranking & Reports Generic Drug
Investigate the Current Status of Rivaroxaban Generic Drug Application in China
2023-03-01
Special Lawsuit
Dutch Pharmaceutical Watchdog Organization Sues Abbvie over Humira Pricing
2023-02-22
Policy American Healthcare
HHS To Test Three New Models to Lower Drug Prices
2023-02-17
Special GSK
Bloomberg Blasts GSK Over Handling of Zantac’s Cancer Risks
2023-02-15
Special H5N1
Avian Flu H5N1: Fear Over Potential Spread Among Humans and What We Should Know
2023-02-15
Special JPM
Biotech Showcase 2023: Digital Medicine Innovation: Its Time is Now
2023-02-01
Special Johnson & Johnson
J&J’s Market Value Plummets by $17 billion After Appeals Court Denies Bankruptcy Escape
2023-01-31
Special mRNA
Moving Beyond COVID With mRNA Technology
2023-01-18
Special Asia Microbiome Conference
Rob Knight and Jing-Yuan Fu Elaborate On Microbiome Research Trends at the 7th Asia Microbiome Conference(AMC)
2023-01-17Partner
Go Prime Gene Therapy
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Special JPM
JPM23: More Deals as JP Morgan Healthcare Conference 2023 Enters the Third Day
2023-01-12
JPM23: More Deals Defining JP Morgan Healthcare Conference 2023 Day Two
2023-01-11
Special JPM
JPM23: Development and Strategic Updates from JP Morgan Healthcare Conference 2023 Day Two
2023-01-10
Licensing JPM
JPM23: Partnerships Take off From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
M&A JPM
JPM23: Acquisition Announcements From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
1 2 3 4 … 17
LATEST
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
2023-03-24
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
2023-03-23
READ MORE
EVENT
2023-03-28
Reuters Events: Pharma USA 2023
Philadelphia, USA
2023-04-24
Cell & Gene Therapy Summit 2023
Brussels, Belgium
2023-04-28
Boston Chinese Investment Club 2023 Biotech Pitch Competition
Boston, USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top